The Proportion of Rifabutin-susceptible Strains among Rifampicin- resistant Isolates and Its Specific rpoB Mutations.
Woo Jin Lew, Young Kil Park, Hee Jin Kim, Chulhun Chang, Gill Han Bai, Sung Kyu Kim
Tuberc Respir Dis. 2005;59(3):257-265.   Published online 2005 Sep 1     DOI:
Citations to this article as recorded by Crossref logo
Critical Review
H. Manisha Yapa, Marta Boffito, Anton Pozniak
JAIDS Journal of Acquired Immune Deficiency Syndromes.2016; 72(2): 138.     CrossRef
Diagnosis and Treatment of Multidrug-Resistant Tuberculosis
Tae Sun Shim
Korean Journal of Medicine.2015; 88(5): 509.     CrossRef
The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis
Kyung-Wook Jo, Wonjun Ji, Yoonki Hong, Sang-Do Lee, Woo Sung Kim, Dong Soon Kim, Tae Sun Shim
Respiratory Medicine.2013; 107(2): 292.     CrossRef
Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
Tae Sun Shim, Kyung-Wook Jo
Infection & Chemotherapy.2013; 45(4): 367.     CrossRef
The Up-to-date of Anti-Tuberculosis Treatment
Woo-Jin Lew
Tuberculosis and Respiratory Diseases.2006; 60(3): 270.     CrossRef
Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains
Byoung Ju Kim, Seung Hwan Oh, Eun Jin Cho, Seung Kyu Park
Tuberculosis and Respiratory Diseases.2006; 60(2): 171.     CrossRef